Carbohydrate metabolism in children receiving growth hormone for 5 years: Chronic renal insufficiency compared with growth hormone deficiency, Turner syndrome, and idiopathic short stature

Pediatric Nephrology

Volumn 10, Issue 3, 1996, Pages 261-263

  Saenger, Paul ^a   Attie, Kenneth M ^c   DiMartino Nardi, Joan ^a   Fine, Richard N ^b  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c GENENTECH INC   (United States)

Author keywords

Carbohydrate metabolism; Chronic renal insufficiency; Growth hormone

Indexed keywords

CARBOHYDRATE; GLUCOSE; GROWTH HORMONE; HEMOGLOBIN A1C; INSULIN;

CARBOHYDRATE METABOLISM; CHRONIC KIDNEY FAILURE; COMPARATIVE STUDY; CONFERENCE PAPER; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; GROWTH DISORDER; GROWTH HORMONE DEFICIENCY; HUMAN; INSULIN BLOOD LEVEL; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SHORT STATURE; TURNER SYNDROME;

BLOOD GLUCOSE; CARBOHYDRATE METABOLISM; CHILD; CHOLESTEROL; GROWTH DISORDERS; GROWTH HORMONE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; KIDNEY FAILURE, CHRONIC; POSTPRANDIAL PERIOD; POTASSIUM; SODIUM; THYROXINE; TRIGLYCERIDES; TURNER SYNDROME;

EID: 0029994322     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00866753     Document Type: Article

References (14)

1. Fine RN, Kohaut EC, Brown D, Perlman AJ for the Genentech Collaborative Study Group (1994) Growth after recombinant human growth hormone treatment in children with chronic renal failure: report of a multicenter randomized double-blind plaebo-controlled study. J Pediatr 124: 374-382
2. Fine RN, Attie KM, Kuntze J, Brown DF, Kohaut EC for the Genentech Collaborative Study Group (1995) Recombinant human growth hormone in infants and young children with chronic renal insufficiency. Pediatr Nephrol 9: 451-457
3. Rosenfeld RG, Frane J, Attie KM, Brasel JA, Attie KM, Burstein S, Cara JF, Chernausek S, Gotlin RW, Kuntze J, Lippe BM, Mahoney PC, Moore WV, Saenger P, Johanson AJ (1992) Six-year results of a randomized, prospective trial of human growth hormone and oxandrolone in Turner syndrome. J Pediatr 121: 49-55
4. Attie KM, Chernausek S, Frane J, Rosenfeld RG for Genentech Study Group (1995) Growth hormone use in Turner syndrome: a preliminary report on the effect of early vs. delayed estrogen. In: Albertsson-Wikland K, Ranke MB (eds) Turner syndrome in a life span perspective: research and clinical aspects. Elsevier Amsterdam, pp 175-181
5. Hintz RL, Attie KM, Johanson AJ, Baptista J, Roche AF and the Genentech Study Group (1995) Near final height in GH-treated short children without classical GH deficiency. Pediatr Res 37: 91A
6. Hopwood NJ, Hintz RL, Gertner JM, Attie KM, Johanson AJ, Baptista J, Kuntze J, Blizzard RM, Cara JF, Chernausek SD, Kaplan SL, Lippe BM, Plotnick LP, Saenger P (1993) Growth acceleration of non-growth hormone deficient children with marked short stature during three years of growth hormone therapy. J Pediatr 123: 215-222
7. Kaplan S, Underwood LE, August GP, Bell JJ, Blethen SL, Blizzard RM, Brown DR, Foley TP, Hintz RL, Hopwood NJ, Johansen A, Kirkland RT, Plotnick LP, Rosenfeld RG, Van Wyk JJ (1986) Clinical studies with recombinant-DNA-derived methionyl human growth hormone in growth hormone deficient children. Lancet I: 697-700
8. Tönshoff B, Haffner D, Mehls O, Dietz M, Ruder H, Blum WF, Heinrich U, Stoever B (1993) Efficacy and safety of growth hormone treatment in short children with renal allografts: three year experience. Kidney Int 44: 199-207
9. Saenger P, DiMartino-Nardi J (1992) Endocrine system in uremia. In: Edelmann CE (ed) Pediatric kidney disease, 2nd edn. Little Brown, Boston, pp 765-782
10. Tönshoff B, Tönshoff C, Mehls O, Pinkowski J, Blum WF, Heinrich U, Stoever B, Gretz N (1992) Growth hormone treatment in children with preterminal chronic renal failure: no adverse effect on glomerular filtration rate. Eur J Pediatr 151: 601-607
11. Walker J, Chaussain JL, Bougneres PF (1989) Growth hormone treatment of children with short stature increases insulin secretion but does not impair glucose disposal. J Clin Endocrinol Metab 69: 253-258
12. Saenger P, Attie K, Fine R, Hintz R, DiMartino-Nardi J and the Genentech Collaborative Group (1995) Metabolic consequences of 5 year growth hormone deficiency and other forms of short stature. Pediatr Res 37: 98A
13. Lesage C, Walker J, Landier F, Chatelain P, Chaussain JL, Bougneres PF (1991) Near normalization of adolescent height with growth hormone therapy in very short children without growth hormone deficiency. J Pediatr 119: 29
14. Saenger P, Wesoly S, Wasserman EJ, Glickstein J, Issenberg H (1996) Safety aspects of GH therapy in Turner syndrome (TS): no evidence for ventricular hypertrophy (VH) and normalization of insulin levels after discontinuation of GH. Pediatr Res 39: 98A